FDA DMB Acknowledgement Letter to Emprise Pharma LLC

FDA DMB issued an acknowledgement letter to Emprise Pharma LLC responding to a submission filed on behalf of Shandong New Time Pharmaceutical Co., Ltd. The letter confirms receipt of the filing but does not contain any substantive approval, denial, or regulatory determination.\n\nPharmaceutical companies and drug manufacturers submitting applications or supplements to FDA should be aware that acknowledgement letters are routine administrative documents. Recipients should continue monitoring for substantive responses from FDA regarding any pending applications or manufacturing supplements.